Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ALK Alutard birch + ALK Alutard timothy
- Development stage
- Unknown
- Lead developer
- ALK Abelló
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
A combination allergen immunotherapy product containing standardized allergen extracts of birch pollen (Betula verrucosa) and timothy grass pollen (Phleum pratense) for subcutaneous injection. This combination is used to treat patients with allergic rhinitis and/or allergic asthma who are sensitized to both birch and grass pollen allergens. The treatment works by gradually exposing the immune system to increasing amounts of allergens, which helps to modify the immune response and reduce allergic symptoms when exposed to these allergens naturally.
- Brand names
- Alutard SQ Birch + Alutard SQ Timothy grass
- Other names
- Alutard SQ Birch + Alutard SQ TimothyAlutard SQ Betula verrucosa + Alutard SQ Phleum pratense
02
Targets
sIgG4 (Allergen-specific immunoglobulin G4)TCR (T cell antigen receptor complex)IgE (Immunoglobulin E)
Beyond the preview
Go deeper on ALK Alutard birch + ALK Alutard timothy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ALK Alutard birch + ALK Alutard timothy.